000 | 01973 a2200565 4500 | ||
---|---|---|---|
005 | 20250517144805.0 | ||
264 | 0 | _c20170602 | |
008 | 201706s 0 0 eng d | ||
022 | _a1090-2104 | ||
024 | 7 |
_a10.1016/j.bbrc.2017.03.119 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTang, Lu | |
245 | 0 | 0 |
_aUrolithin A alleviates myocardial ischemia/reperfusion injury via PI3K/Akt pathway. _h[electronic resource] |
260 |
_bBiochemical and biophysical research communications _c05 2017 |
||
300 |
_a774-780 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAnimals, Newborn |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCardiotonic Agents _xantagonists & inhibitors |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aChromones _xpharmacology |
650 | 0 | 4 |
_aCoumarins _xantagonists & inhibitors |
650 | 0 | 4 | _aGene Expression Regulation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aMorpholines _xpharmacology |
650 | 0 | 4 |
_aMyocardial Reperfusion Injury _xdrug therapy |
650 | 0 | 4 |
_aMyocardium _xmetabolism |
650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xgenetics |
650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
650 | 0 | 4 | _aPrimary Cell Culture |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aSignal Transduction |
700 | 1 | _aMo, Yingli | |
700 | 1 | _aLi, Yunpeng | |
700 | 1 | _aZhong, Yongkang | |
700 | 1 | _aHe, Shangfei | |
700 | 1 | _aZhang, Ya | |
700 | 1 | _aTang, Ying | |
700 | 1 | _aFu, Shanshan | |
700 | 1 | _aWang, Xianbao | |
700 | 1 | _aChen, Aihua | |
773 | 0 |
_tBiochemical and biophysical research communications _gvol. 486 _gno. 3 _gp. 774-780 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbrc.2017.03.119 _zAvailable from publisher's website |
999 |
_c27017039 _d27017039 |